Biotin Anti-Human CD29 Antibody[TS2/16.2.1]

Biotin Anti-Human CD29 Antibody[TS2/16.2.1]

The Biotin Anti-Human CD29 Antibody[TS2/16.2.1] is a highly specific and reliable tool for the detection and analysis of CD29, also known as integrin beta-1, on human cells. This antibody is conjugated with biotin, allowing for easy and efficient detection using streptavidin-based detection systems. CD29 is a cell surface glycoprotein that plays a crucial role in cell adhesion and migration, making it an important target for research in various fields, including immunology, cancer biology, and regenerative medicine.

The TS2/16.2.1 antibody is derived from a hybridoma cell line and has been extensively characterized for its specificity and functionality. It recognizes an epitope on the extracellular domain of CD29, ensuring accurate and reliable detection. This antibody has been validated for use in various applications, including flow cytometry, immunohistochemistry, and western blotting, providing researchers with flexibility in experimental design.

In addition to its high specificity, the Biotin Anti-Human CD29 Antibody[TS2/16.2.1] offers excellent sensitivity, allowing for the detection of low levels of CD29 expression. Its biotin conjugation enables easy and efficient detection using streptavidin-based detection systems, providing researchers with a streamlined workflow. With its reliable performance and versatility, this antibody is an invaluable tool for studying CD29 expression and its functional implications in various biological processes.